(Q34996991)

5 August 2017

1 reference

title

Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities (English)

1 reference

5 August 2017

0 references

1 reference

1 reference

1

Derek LeRoith

1 reference

PubMed ID

12431757

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

American Journal of Medicine

5 August 2017

1 reference

5 August 2017

113 Suppl 6A

1 reference

5 August 2017

3S-11S

1 reference

Tactics for type II diabetes

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Fatty acids and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Assessing the potential for alpha-glucosidase inhibitors in prediabetic states.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Banting lecture 1990. Beta-cells in type II diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Triggering and amplifying pathways of regulation of insulin secretion by glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Of mice and men: K(ATP) channels and insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

7 January 2021

Evening insulin strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Intracellular organization of insulin signaling and GLUT4 translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Hexosamines as mediators of nutrient sensing and regulation in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Free fatty acids-the link between obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Skeletal muscle triglyceride levels are inversely related to insulin action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

The hormone resistin links obesity to diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901276-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(02)01276-7

1 reference

5 August 2017

1 reference

PubMed ID

12431757